International Business Machines Corporation (NYSE:IBM) just experienced its sharpest one day drop in more than 25 years, tumbling 13% Tuesday, but Wedbush believes the market may have overreacted and ...
IBM's ( IBM) share price plunged 13% by the closing bell on Tuesday, but the analysts at Wedbush label the sell-off as unwarranted, and the decline presents an attractive buying opportunity for ...
IBM has secured a contract with a ceiling value of $112 million for up to five years from the Department of War's (DoW) Defense Commissary Agency (DeCA) to modernize pricing displays across ...
Listed Company Introduces Longevity Blood Test Integrating Inflammatory Biomarkers, Dietary Habits, and Curated Scientific ...
AI disruption fears are sparking a sharp market rotation after a $275B software wipeout and hits to cybersecurity and IBM. Click here to get the key takeaways now.
Recently Nasdaq-Listed Company Introduces Longevity Blood Test Integrating Inflammatory Biomarkers, Dietary Habits, and Curated Scientific Research to Deliver Personalized Health Insights GAITHERSBURG ...
Jeffrey Borek of IBM and Jens Neuhüttler of Fraunhofer Institute bring service science and innovation leadership to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results